Suppr超能文献

通过激活5-羟色胺(5-HT)1A受体诱导腹侧被盖区多巴胺能神经元爆发式放电:WAY 100,635对高选择性配体氟辛克生和S 15535的可逆作用

Induction of burst firing in ventral tegmental area dopaminergic neurons by activation of serotonin (5-HT)1A receptors: WAY 100,635-reversible actions of the highly selective ligands, flesinoxan and S 15535.

作者信息

Lejeune F, Millan M J

机构信息

Department of Psychopharmacology, Institut de Recherches Servier, Centre de Recherches de Croissy, Croissy-sur-Seine, France.

出版信息

Synapse. 1998 Oct;30(2):172-80. doi: 10.1002/(SICI)1098-2396(199810)30:2<172::AID-SYN7>3.0.CO;2-9.

Abstract

This study examined the influence of the highly selective 5-HT1A receptor ligands, flesinoxan, S 15535, and WAY 100,635, upon the electrical activity of dopaminergic neurons in the ventral tegmental area (VTA), as compared to serotonergic neurons in the dorsal raphe nucleus (DRN) of anesthetized rats. Flesinoxan, a high-efficacy agonist at both pre- and postsynaptic 5-HT1A receptors, dose-dependently (inhibitory dose (ID)50 = 19.5 microg/kg, i.v.) inhibited the firing of DRN serotonergic neurons. This action was abolished by WAY 100,635 (31 microg/kg i.v.) which is an antagonist at pre- and postsynaptic 5-HT1A receptors. S 15535, which behaves as an agonist and partial agonist at pre- and postsynaptic 5-HT1A receptors, respectively, similarly abolished DRN firing in a WAY 100,635-reversible fashion with an ID50 of 6.1 microg/kg, i.v. In contrast to these actions, both flesinoxan (> or = 500 microg/kg, i.v.) and S 15535 (> or = 125 microg/kg, i.v.) dose-dependently and monophasically increased the firing rate of dopaminergic neurons in the VTA, with maximal effects of 70.1 +/- 17.2% and 33.7 +/- 5.3%, respectively. Further, VTA dopaminergic neurons displaying a regular firing pattern were transformed into a bursting mode. This influence of flesinoxan and S 15535 on VTA cells was abolished by WAY 100,635. Administered alone, WAY 100,635 did not significantly modify the activity of either serotonergic or dopaminergic neurons. In conclusion, the present findings show that selective activation of 5-HT1A receptors not only inhibits serotonergic neurones but also elicits a (possibly related) increase in VTA dopaminergic output. A facilitatory influence of flesinoxan, S 15535, and other selective 5-HT1A receptor ligands upon mesocortical dopaminergic pathways may contribute to their putative antidepressant properties.

摘要

本研究检测了高选择性5-HT1A受体配体氟西汀、S 15535和WAY 100635对麻醉大鼠腹侧被盖区(VTA)多巴胺能神经元电活动的影响,并与中缝背核(DRN)中5-羟色胺能神经元进行比较。氟西汀是一种对突触前和突触后5-HT1A受体均有高效能的激动剂,它能剂量依赖性地(抑制剂量(ID)50 = 19.5微克/千克,静脉注射)抑制DRN中5-羟色胺能神经元的放电。WAY 100635(31微克/千克,静脉注射)可消除这一作用,WAY 100635是突触前和突触后5-HT1A受体的拮抗剂。S 15535在突触前和突触后5-HT1A受体上分别表现为激动剂和部分激动剂,同样以WAY 100635可逆的方式消除DRN的放电,ID50为6.1微克/千克,静脉注射。与这些作用相反,氟西汀(≥500微克/千克,静脉注射)和S 15535(≥125微克/千克,静脉注射)均剂量依赖性且单相性地增加VTA中多巴胺能神经元的放电频率,最大效应分别为70.1±17.2%和33.7±5.3%。此外,表现为规则放电模式的VTA多巴胺能神经元转变为爆发模式。氟西汀和S 15535对VTA细胞的这种影响被WAY 100635消除。单独给药时,WAY 100635对5-羟色胺能或多巴胺能神经元的活性均无显著影响。总之,目前的研究结果表明,5-HT1A受体的选择性激活不仅抑制5-羟色胺能神经元,还引发(可能相关的)VTA多巴胺能输出增加。氟西汀、S 15535和其他选择性5-HT1A受体配体对中皮质多巴胺能通路的促进作用可能有助于其假定的抗抑郁特性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验